XML 22 R124.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Information (Quarterly Comparison of Financial Statements as Previously Filed - Statement of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 25, 2012
Jun. 30, 2013
Jun. 24, 2012
Sep. 29, 2013
Sep. 23, 2012
Dec. 29, 2013
Dec. 30, 2012
Dec. 25, 2011
Net Cash Provided by (Used in) Operating Activities [Abstract]                  
Net loss $ (7,481) $ (11,388) $ (20,913) $ (106,737) $ (13,781) $ (112,546) $ (18,927) $ (146,979) $ (83,561)
Depreciation and amortization 6,962 8,313 13,666 15,940 20,094 23,190 26,373 30,369 36,278
Amortization of debt issuance costs 347 267 821 535 1,221 1,994 2,207 2,345 1,070
Interest on financing liability 505 479 1,013 941 1,536 1,404 2,082 1,893 977
Deferred taxes (393) (1,028) (768) (1,219) (858) (1,449) (3,565) (2,930) 40,888
Stock-based compensation 1,972 1,867 3,859 2,814 5,145 3,737 6,369 4,753 7,408
Provision for losses on accounts receivable (699) 1,390 (522) 3,296 (638) 3,400 (435) 3,024 3,765
Excess tax benefit on stock compensation (23) 73 (122) (97) (594) (97) (600) (98) (634)
Loss (gain) on disposal of fixed assets 170 (68) 375 (295) 343 (1,069) 564 (1,326) 106
Litigation settlement (6,584) 0 (6,584)   (6,584)   (6,584) 295 943
Asset impairment       672   1,442 4,820 1,771 3,373
Goodwill impairment       64,807   64,807 0 106,348 3,411
Gain on sale of subsidiary     (248)   (248)   (248) (1,657) 0
Loss on sale of discontinued operations     13,024   13,043   13,598 15 0
Restructuring-related asset impairment 731   731 5,297 731 6,156 1,211 6,506 7,843
Accounts receivable 34,851 44,826 37,308 34,151 20,702 33,065 12,903 26,317 (25,757)
Inventories (1,254) (3,091) (2,529) 7,756 (12,441) 19,981 (948) 37,947 (23,947)
Other assets 6,764 (3,950) 148 (1,198) (6,912) 633 4,947 7,828 (15,015)
Accounts payable (2,031) (20,437) 8,267 (12,117) 2,326 (4,562) 1,954 (2,185) 1,064
Income taxes (2,462) (3,594) (2,329) (3,325) (1,950) (3,319) (198) (1,502) (506)
Unearned revenues - current (4,679) (1,201) (3,840) (8,653) (4,424) (9,635) (6,244) (6,923) 9,351
Restructuring reserve (3,063) (5,658) (5,059) 2,125 (5,923) (1,983) (1,598) (8,178) 10,544
Other liabilities (10,590) (120) (19,339) 6,063 (14,995) (3,806) (16,611) 4,732 2,326
Net cash provided by operating activities 13,043 6,680 16,959 10,756 (4,207) 21,343 21,070 62,365 (20,073)
Net Cash Provided by (Used in) Investing Activities [Abstract]                  
Acquisition of property, plant, and equipment and intangibles (1,363) (5,365) (3,310) (8,383) (5,955) (10,415) (8,946) (12,401) (22,981)
Change in restricted cash   25   39   291 0 291 15
Proceeds from sale of real estate           4,560 0 4,560 0
Net cash proceeds from the sale of discontinued operations     1,290   1,502   1,573 1,180 0
Net cash proceeds from the sale of subsidiary     227   227   227 2,250 0
Other investing activities 440 288 921 518 1,151 1,148 1,848 1,671 623
Net cash used in investing activities (923) (5,052) (872) (7,826) (3,075) (4,416) (5,298) (2,449) (98,280)
Net Cash Provided by (Used in) Financing Activities [Abstract]                  
Proceeds from stock issuances 600 521 1,545 623 2,980 922 4,073 1,653 2,210
Excess tax benefit on stock compensation 23 (73) 122 97 594 97 600 98 634
Proceeds from short-term debt 2,272 2,837 2,759 2,863 2,759 3,451 2,759 3,467 8,565
Payment of short-term debt (248) (2,613) (2,561) (10,765) (2,561) (11,481) (2,561) (11,869) (7,895)
Net change in factoring and bank overdrafts (431) (633) (339) (1,475) (441) (9,121) (877) (8,932) (4,364)
Proceeds from long-term debt   2,000   3,000   3,000 99,098 3,000 74,117
Payment of long-term debt (71) (5,321) (10,113) (5,380) (17,138) (20,439) (112,664) (20,498) (67,370)
Proceeds from financing liability             0 0 31,407
Debt issuance costs           (2,113) (1,765) (2,085) 0
Net cash (used in) provided by financing activities 2,145 (3,282) (8,587) (11,037) (13,807) (35,684) (11,337) (35,166) 37,304
Effect of foreign currency rate fluctuations on cash and cash equivalents (2,015) 1,626 (3,204) (960) (1,544) 549 (1,691) 747 1,908
Net increase (decrease) in cash and cash equivalents 12,250 (28) 4,296 (9,067) (22,633) (18,208) 2,744 25,497 (79,141)
Cash and cash equivalents 131,079 93,304 123,125 84,265 96,196 75,124 121,573 118,829 93,332
As Previously Reported
                 
Net Cash Provided by (Used in) Operating Activities [Abstract]                  
Net loss (6,342) (11,270) (19,357) (105,456) (11,733) (110,841)   (146,405) (66,626)
Depreciation and amortization 7,309 8,580 14,487 16,475 21,315 25,184   32,714 37,348
Amortization of debt issuance costs 0 0 0 0 0 0   0 0
Interest on financing liability 0 0 0 0 0 0   0 0
Deferred taxes (114) (434) (305) (916) (228) (967)   (2,075) 47,612
Stock-based compensation 1,972 1,867 3,859 2,814 5,145 3,737   4,753 7,408
Provision for losses on accounts receivable (699) 1,390 (522) 3,296 (638) 3,400   3,024 3,765
Excess tax benefit on stock compensation (23) 73 (122) (97) (594) (97)   (98) (634)
Loss (gain) on disposal of fixed assets 170 (68) 375 (295) 343 (1,069)   (1,326) 106
Litigation settlement (6,584) 0 (6,584)   (6,584)     0 0
Asset impairment       672   1,442   1,771 3,373
Goodwill impairment       64,807   64,807   106,348 3,411
Gain on sale of subsidiary     (248)   (248)     (1,657)  
Loss on sale of discontinued operations     13,024   13,043     15  
Restructuring-related asset impairment 731   731 5,297 731 6,156   6,506 7,843
Accounts receivable 39,180 44,636 41,613 33,961 25,020 32,875   22,105 (25,567)
Inventories (1,181) (2,968) (2,456) 7,357 (12,514) 19,634   37,748 (23,821)
Other assets 10,302 (3,950) 2,690 (1,198) (3,824) 633   5,357 (14,065)
Accounts payable (6,973) (20,437) 3,351 (12,117) (2,604) (4,562)   2,631 1,064
Income taxes (2,462) (3,594) (2,329) (3,325) (1,950) (3,319)   (1,502) (506)
Unearned revenues - current (8,846) (1,728) (7,007) (9,166) (8,139) (10,143)   (4,393) 10,780
Restructuring reserve (3,063) (5,658) (5,059) 2,125 (5,923) (1,983)   (8,178) 10,544
Other liabilities (10,334) 89 (19,182) 6,371 (14,825) (3,696)   4,875 8,350
Net cash provided by operating activities 13,043 6,528 16,959 10,605 (4,207) 21,191   62,213 10,385
Net Cash Provided by (Used in) Investing Activities [Abstract]                  
Acquisition of property, plant, and equipment and intangibles (1,363) (5,365) (3,310) (8,383) (5,955) (10,415)   (12,401) (22,981)
Change in restricted cash   25   39   291   291 15
Proceeds from sale of real estate           4,560   4,560  
Net cash proceeds from the sale of discontinued operations     1,290   1,502     1,180  
Net cash proceeds from the sale of subsidiary     227   227     2,250  
Other investing activities 440 288 921 518 1,151 1,148   1,671 623
Net cash used in investing activities (923) (5,052) (872) (7,826) (3,075) (4,416)   (2,449) (98,280)
Net Cash Provided by (Used in) Financing Activities [Abstract]                  
Proceeds from stock issuances 600 521 1,545 623 2,980 922   1,653 2,210
Excess tax benefit on stock compensation 23 (73) 122 97 594 97   98 634
Proceeds from short-term debt 2,272 2,837 2,759 2,863 2,759 3,451   3,467 8,565
Payment of short-term debt (248) (2,613) (2,561) (10,765) (2,561) (11,481)   (11,869) (7,895)
Net change in factoring and bank overdrafts (431) (633) (339) (1,475) (441) (9,121)   (8,932) (4,364)
Proceeds from long-term debt   2,000   3,000   3,000   3,000 74,117
Payment of long-term debt (71) (5,321) (10,113) (5,380) (17,138) (20,439)   (20,498) (67,370)
Proceeds from financing liability                 0
Debt issuance costs           (2,113)   (2,085)  
Net cash (used in) provided by financing activities 2,145 (3,282) (8,587) (11,037) (13,807) (35,684)   (35,166) 5,897
Effect of foreign currency rate fluctuations on cash and cash equivalents (2,015) 1,629 (3,204) (958) (1,544) 552   750 3,006
Net increase (decrease) in cash and cash equivalents 12,250 (177) 4,296 (9,216) (22,633) (18,357)   25,348 (78,992)
Cash and cash equivalents 131,079 93,304 123,125 84,265 96,196 75,124   118,829 93,481
Restatement Adjustments
                 
Net Cash Provided by (Used in) Operating Activities [Abstract]                  
Net loss (1,139) (118) (1,556) (1,281) (2,048) (1,705)   (574) (16,935)
Depreciation and amortization 0 0 0 0 0 0   0 0
Amortization of debt issuance costs 0 0 0 0 0 0   0 0
Interest on financing liability 505 479 1,013 941 1,536 1,404   1,893 977
Deferred taxes (279) (594) (463) (303) (630) (482)   (855) (6,724)
Stock-based compensation 0 0 0 0 0 0   0 0
Provision for losses on accounts receivable 0 0 0 0 0 0   0 0
Excess tax benefit on stock compensation 0 0 0 0 0 0   0 0
Loss (gain) on disposal of fixed assets 0 0 0 0 0 0   0 0
Litigation settlement 0 0 0   0     0 0
Asset impairment       0   0   0 0
Goodwill impairment       0   0   0 0
Gain on sale of subsidiary     0   0     0  
Loss on sale of discontinued operations     0   0     0  
Restructuring-related asset impairment 0   0 0 0 0   0 0
Accounts receivable (4,329) 190 (4,305) 190 (4,318) 190   4,212 (190)
Inventories (73) (123) (73) 399 73 347   199 (126)
Other assets (3,538) 0 (2,542) 0 (3,088) 0   2,471 (950)
Accounts payable 4,942 0 4,916 0 4,930 0   (4,816) 0
Income taxes 0 0 0 0 0 0   0 0
Unearned revenues - current 4,167 527 3,167 513 3,715 508   (2,530) (1,429)
Restructuring reserve 0 0 0 0 0 0   0 0
Other liabilities (256) (209) (157) (308) (170) (110)   152 (5,081)
Net cash provided by operating activities 0 152 0 151 0 152   152 (30,458)
Net Cash Provided by (Used in) Investing Activities [Abstract]                  
Acquisition of property, plant, and equipment and intangibles 0 0 0 0 0 0   0 0
Change in restricted cash   0   0   0   0 0
Proceeds from sale of real estate           0   0  
Net cash proceeds from the sale of discontinued operations     0   0     0  
Net cash proceeds from the sale of subsidiary     0   0     0  
Other investing activities 0 0 0 0 0 0   0 0
Net cash used in investing activities 0 0 0 0 0 0   0 0
Net Cash Provided by (Used in) Financing Activities [Abstract]                  
Proceeds from stock issuances 0 0 0 0 0 0   0 0
Excess tax benefit on stock compensation 0 0 0 0 0 0   0 0
Proceeds from short-term debt 0 0 0 0 0 0   0 0
Payment of short-term debt 0 0 0 0 0 0   0 0
Net change in factoring and bank overdrafts 0 0 0 0 0 0   0 0
Proceeds from long-term debt   0   0   0   0 0
Payment of long-term debt 0 0 0 0 0 0   0 0
Proceeds from financing liability                 31,407
Debt issuance costs           0   0  
Net cash (used in) provided by financing activities 0 0 0 0 0 0   0 31,407
Effect of foreign currency rate fluctuations on cash and cash equivalents 0 (3) 0 (2) 0 (3)   (3) (1,098)
Net increase (decrease) in cash and cash equivalents 0 149 0 149 0 149   149 (149)
Cash and cash equivalents $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ (149)